Medical Letter on the CDC & FDA
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC & FDA
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Advantage Medical Devices
Advantage Medical Devices Receives FDA Clearance for VantageCath
May 18th, 2008
The U.S. Food and Drug Administration has cleared for marketing a new safety engineered short-term peripheral Intra-Venous (IV) Catheter. The product, VantageCath(TM), is designed to significantly reduce exposure to bloodborne pathogens during the placement of the catheter and also provide the clinician with desirable feature sets. Existing safety engineered peripheral IVs have mechanisms to protect the needle that has been contaminated but do not usually address the problem of blood leaking out of an open hub. The VantageCath(TM) utilizes a closed-hub system that eliminates the need to tamponade above the site while connecting tubing or saline lock. ...
Source: Medical Letter on the CDC & FDA (2008-05-18)
|
